Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...

Chronic Kidney Disease III: Interprofessional Care

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...

Dialysis

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

Acute Kidney Injury II: Pathophysiology

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...

Chronic Kidney Disease IV: Nursing Management

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Next-Generation Sequencing Defines a Molecularly Confirmed ARPKD Core Within the Broader <i>PKHD1</i>-Associated Disease Spectrum.

Genes·2026

Same author

A Spanish Family with Gordon Syndrome Due to a Variant in the Acidic Motif of <i>WNK1</i>.

Genes·2023

Same author

Rapidly Progressing to ESRD in an Individual with Coexisting ADPKD and Masked Klinefelter and Gitelman Syndromes.

Genes·2022

Same author

Birth of two healthy girls following preimplantation genetic diagnosis and gestational surrogacy in a rapidly progressive autosomal dominant polycystic kidney disease case using tolvaptan.

Clinical kidney journal·2021

Same author

Historical and geographical distribution of the founder mutation c.610G>A; p.Ala204Thr in the <i>CLCNKB</i> gene linked to Bartter syndrome type III in Spain.

Clinical kidney journal·2021

Same author

Co-occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2.

Molecular genetics & genomic medicine·2020

Search research articles

Related Experiment Video

Updated: Jul 13, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Malignancy and chronic renal failure.

Ramon Peces¹

¹Servicio de Nefrologia, Hospital Universitario La Paz, Madrid, Spain.

Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia

|July 28, 2007

Summary

Patients with end-stage renal disease (ESRD) face increased cancer risks, particularly renal cell carcinoma (RCC). Factors like acquired cystic kidney disease (ACKD) and immunosuppression post-transplant contribute to higher malignancy incidence.

More Related Videos

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

Related Experiment Videos

Last Updated: Jul 13, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

Area of Science:

Nephrology and Oncology
Cancer epidemiology in renal disease patients

Background:

Patients with end-stage renal disease (ESRD) exhibit a higher incidence of various cancers, including lymphomas and carcinomas of the kidney, prostate, liver, and uterus.
Renal cell carcinoma (RCC) shows a particularly elevated prevalence in ESRD patients.
Acquired cystic kidney disease (ACKD), common in patients undergoing renal replacement therapy (RRT), is a significant predisposing factor for RCC.

Discussion:

Risk factors for malignancy in ESRD patients include cytotoxic drug use and analgesic abuse.
Malignancy post-renal transplantation is a major concern, with lymphoproliferative disorders and skin carcinomas being most common.
Immunosuppression type and genetic/environmental factors influence malignancy type and incidence, varying by country.

Key Insights:

ESRD patients have a heightened risk of specific cancers, notably RCC, linked to ACKD development.
Renal transplantation increases malignancy risk, with distinct patterns observed early and late post-transplant.
Understanding these risks is crucial for managing cancer in ESRD and post-transplant populations.

Outlook:

Further research into the mechanisms linking ACKD and RCC is warranted.
Optimizing immunosuppression protocols may mitigate post-transplant cancer risks.
Long-term surveillance and tailored screening strategies are essential for ESRD patients and transplant recipients.